본문으로 건너뛰기
← 뒤로

Prostate-Related Germline Variant Frequencies Detected in a Cohort of Men With Metastatic Prostate Cancer in Northern India.

1/5 보강
JCO precision oncology 📖 저널 OA 52.3% 2022: 2/2 OA 2023: 2/3 OA 2024: 2/5 OA 2025: 24/51 OA 2026: 26/46 OA 2022~2026 2025 Vol.9() p. e2500130
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: metastatic prostate cancer from India
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
We found that the number of variants in this group was similar to those from other parts of the world, including more found in a gene called .

Batra A, Cockburn JG, Mittal A, Bernardino RM, Sildva T, Wettstein MS

📝 환자 설명용 한 줄

[PURPOSE] Although prostate cancer is generally associated with favorable outcomes, metastatic disease remains incurable.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Batra A, Cockburn JG, et al. (2025). Prostate-Related Germline Variant Frequencies Detected in a Cohort of Men With Metastatic Prostate Cancer in Northern India.. JCO precision oncology, 9, e2500130. https://doi.org/10.1200/PO-25-00130
MLA Batra A, et al.. "Prostate-Related Germline Variant Frequencies Detected in a Cohort of Men With Metastatic Prostate Cancer in Northern India.." JCO precision oncology, vol. 9, 2025, pp. e2500130.
PMID 40638876 ↗
DOI 10.1200/PO-25-00130

Abstract

[PURPOSE] Although prostate cancer is generally associated with favorable outcomes, metastatic disease remains incurable. Additionally, a subset of individuals with high-risk or metastatic disease are likely to harbor at least one germline variant in known prostate cancer association genes. Because of differences in cohort selection and sequencing strategies, the prevalence of germline variants in global populations is unclear.

[METHODS] A whole-exome sequencing (WES) approach was used to explore germline variants in a cohort of patients with metastatic prostate cancer from India. In total, 276 individuals treated at the All India Institute of Medical Sciences in New Delhi, India, were prospectively and consecutively recruited. Blood specimens underwent standard WES and bioinformatic analysis to determine the prevalence of pathogenic and likely pathogenic (PV/LPV) prostate cancer variants, which were then assessed for associations with clinical features.

[RESULTS] In total, PV/LPVs were detected in 11% of individuals across eight genes linked to prostate cancer, most frequently in BRCA2 (3.98%). The distribution reflects previously published findings from other global cohorts, although frequencies in the prevalence of specific variants differ slightly. No relationship between variant status and clinical features were detected, although analysis of a larger cohort may show otherwise.

[CONCLUSION] These results indicate that germline screening for prostate cancer following existing guidelines yield similar variant detection frequencies when focusing on individuals with metastatic disease in the Indian context. In summary, some men are more likely to develop an advanced form of metastatic prostate cancer than others because of differences in their genes, known as variants. This study looked at the how many of these variants are in a group of patients from India. We found that the number of variants in this group was similar to those from other parts of the world, including more found in a gene called .

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (1)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기